Solidarity trial
The Solidarity trial for treatments is a multinational Phase III-IV clinical trial organized by the World Health Organization (WHO) and partners to compare four untested treatments for hospitalized people with severe COVID-19 illness. The trial was announced 18 March 2020, and as of 1 July, nearly 5,500 patients in 21 countries had been recruited to participate in the trial.

In May, the WHO announced an international coalition for simultaneously developing several candidate vaccines to prevent COVID-19 disease, calling this effort the Solidarity trial for vaccines.

The treatments being investigated are remdesivir, lopinavir/ritonavir combined, lopinavir/ritonavir combined with interferon-beta, and hydroxychloroquine or chloroquine. Hydroxychloroquine or chloroquine investigation was discontinued in June 2020 due to concluding that it provided no benefit.
None
Phase III-IV clinical trial
UNK
Q7817
World Health Organization
Concept
Q84263196
COVID-19
Concept
Q134808
vaccine
Concept
Q28209496
remdesivir
MEDIA
Q3836750
lopinavir/ritonavir
Concept
None
interferon-beta
UNK
Q421094
hydroxychloroquine
Concept
Q422438
chloroquine
Concept
Q89914376
Solidarity trial
MEDIA
Q89914376
Solidarity trial
MEDIA
2020-03-18T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
18 March 2020
DATE
2020-06-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
June 2020
DATE
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
+1^^http://www.w3.org/2001/XMLSchema#decimal
1
NUMBER
+21^^http://www.w3.org/2001/XMLSchema#decimal
21
NUMBER
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
main subject
different from
different from